Page last updated: 2024-08-25

nedaplatin and olaparib

nedaplatin has been researched along with olaparib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Endo, Y; Fujimori, K; Furukawa, S; Kamo, N; Manabu, K; Nishigori, H; Nomura, S; Okabe, C; Sato, T; Soeda, S; Takahashi, T; Ueda, M; Watanabe, T	1

Other Studies

1 other study(ies) available for nedaplatin and olaparib

Article	Year
Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports. Anticancer research, 2020, Volume: 40, Issue:9 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Combined Modality Therapy; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Phthalazines; Piperazines; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome	2020

Article

Year

Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports.

Anticancer research, 2020, Volume: 40, Issue:9

Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Combined Modality Therapy; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Phthalazines; Piperazines; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome

2020